Pain Therapeutics reported $-19917000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
Acelrx Pharmaceuticals ACRX:US $ -8672000 323K
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ 940.9M 409.4M
Cara Therapeutics CARA:US $ -4472000 23.44M
Eisai 4523:JP 7.43B 28.23B
Eli Lilly And LLY:US $ 1650.5M 919.4M
Geron GERN:US $ -27976000 699K
Johnson & Johnson JNJ:US $ 6941M 599M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pain Therapeutics PTIE:US $ -19917000 2.1M
Pfizer PFE:US $ 12099M 2104M